DNA Methylation Algorithms of Aging and Incident Cardiovascular Disease: A Prospective Cohort Study
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.045545 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Xian Cui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic Imaging Center, Shanghai Children's Medical Center School of Medicine, Shanghai Jiao Tong University Shanghai China. Hauptthemen laut MEDLINE: DNA Methylation, Cardiovascular Diseases, Aging, Algorithms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Background
While DNA methylation ( DNAm )‐based algorithms of aging show promise for predicting age‐related diseases, their comparative utility for incident cardiovascular disease ( CVD ) remains underexplored. We aimed to systematically compare 13 DNAm algorithms in relation to CVD risk in older adults.
Methods
This prospective cohort study included 2112 participants from the US HRS (Health and Retirement Study) with baseline DNAm data (2016) and 6‐year follow‐up. DNAm profiling was performed using the Infinium MethylationEPIC BeadChip kit ( EPIC , Illumina, San Diego, CA ). Thirteen widely used DNAm algorithms of aging were evaluated. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% CIs per 1‐SD increase in risk scores for incident CVD, including any CVD, congestive heart failure, and stroke.
Results
During a median of 37 months’ follow‐up, a total of 288 CVD cases (congestive heart failure, 38; stroke, 152) were observed. Zhang_DNAmAge, methylation Pace of Aging, and DNAmGrimAgeAcc showed positive associations with any CVD risk, with HRs per SD increase of 1.25 (95% CI, 1.07–1.45), 1.16 (95% CI, 1.02–1.33), and 1.24 (95% CI, 1.05–1.47), respectively. For specific CVD subtypes, DNAmGrimAge was associated with congestive heart failure risk ( HR , 1.47 [95% CI, 1.11–1.95]), while both mPoA ( HR , 1.24 [95% CI, 1.03–1.49]) and HorvathAcc ( HR , 1.28 [95% CI , 1.07–1.55]) predicted incident stroke. Significant dose–response relationships ( P ‐trend
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diagnostic Imaging Center, Shanghai Children's Medical Center School of Medicine, Shanghai Jiao Tong University Shanghai China.
- School of Global Health, Chinese Centre for Tropical Diseases Research Shanghai Jiao Tong University School of Medicine Shanghai China.
- Hainan International Medical Center Shanghai Jiao Tong University School of Medicine Hainan China.
- Department of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.
ORCID-Profile: Xian Cui, Hui Zhang, Chongyu Ding, Zhaojun Wang, Shiqun Sun, Xiangwei Li
Förderung
- NIA NIH HHS
Zitieren
APA
Cui, X., Yi, C., Zhang, H., Xu, Y., Ding, C., Wang, Z., Sun, S., & Li, X. (2025). DNA Methylation Algorithms of Aging and Incident Cardiovascular Disease: A Prospective Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.045545
Vancouver
Cui X, Yi C, Zhang H, Xu Y, Ding C, Wang Z, et al. DNA Methylation Algorithms of Aging and Incident Cardiovascular Disease: A Prospective Cohort Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.045545
BibTeX
@article{Cui2025,
author = {Cui, Xian and Yi, Chunbei and Zhang, Hui and Xu, Yaqian and Ding, Chongyu and Wang, Zhaojun and Sun, Shiqun and Li, Xiangwei},
title = {DNA Methylation Algorithms of Aging and Incident Cardiovascular Disease: A Prospective Cohort Study},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.045545}
}
EUVIMED